KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sabre (SABR) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Sabre (SABR) over the last 13 years, with Q3 2025 value amounting to $661.7 million.

  • Sabre's Cash & Equivalents fell 105.28% to $661.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $661.7 million, marking a year-over-year decrease of 105.28%. This contributed to the annual value of $724.5 million for FY2024, which is 1176.66% up from last year.
  • Per Sabre's latest filing, its Cash & Equivalents stood at $661.7 million for Q3 2025, which was down 105.28% from $426.1 million recorded in Q2 2025.
  • In the past 5 years, Sabre's Cash & Equivalents ranged from a high of $1.3 billion in Q1 2021 and a low of $426.1 million during Q2 2025
  • For the 5-year period, Sabre's Cash & Equivalents averaged around $806.7 million, with its median value being $724.5 million (2024).
  • Examining YoY changes over the last 5 years, Sabre's Cash & Equivalents showed a top increase of 8992.74% in 2021 and a maximum decrease of 3863.59% in 2021.
  • Sabre's Cash & Equivalents (Quarter) stood at $978.4 million in 2021, then decreased by 18.75% to $794.9 million in 2022, then dropped by 18.45% to $648.2 million in 2023, then increased by 11.77% to $724.5 million in 2024, then fell by 8.66% to $661.7 million in 2025.
  • Its Cash & Equivalents stands at $661.7 million for Q3 2025, versus $426.1 million for Q2 2025 and $651.1 million for Q1 2025.